版本:
中国

BRIEF-Onxeo announces another positive DSMB recommendation for Livatag

Nov 21 Onxeo SA :

* Announces 9th positive DSMB recommendation to continue Livatag relive phase III trial in HCC

* Nine consecutive positive DSMB recommendations reinforce acceptable safety profile of Livatag Source text for Eikon: Further company coverage: (Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐